Product Information
BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.2430 per EA under NDC 68462057701. Its NADAC has been published 134 times since Jan 31, 2024.
FDA first approved this application on Feb 11, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB
Benazepril Hydrochloride and HydrochlorothiazideStrength
10; 12.5 mg/1; mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462057701
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076631FDA Approved
2/11/2004
TE Code
AB
On Market Since
4/4/2014
Pharmacological Classes
Price Statistics
The NADAC for BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB has been published 134 times since Jan 31, 2024, and over the history we have for it it has risen 3.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2430 per EA |
|---|---|
| All-time high | $0.3811 (Apr 10, 2024) |
| All-time low | $0.1399 (Nov 20, 2024) |
| 52-week high | $0.2521 |
| 52-week low | $0.2218 |
| Median price | $0.2352 |
| Average price | $0.2329 |
| Largest weekly change | -50.9% (Apr 17, 2024) |
| Weeks tracked | 134 |
| Tracking since | Jan 31, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.2430 per EA (NDC 68462057701), effective Aug 19, 2026.
How has the price of BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB changed over time?
Over the history we have for it, the NADAC for BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB has risen 3.3%. It has been tracked across 134 weekly CMS publications since Jan 31, 2024.
What are the highest and lowest recorded NADAC prices for BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?
Since Jan 31, 2024, the NADAC for BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB has ranged from a low of $0.1399 (Nov 20, 2024) to a high of $0.3811 (Apr 10, 2024), with a median of $0.2352 per EA.
Are there cheaper alternatives to BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?
BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB (NDC 68462057701) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.